Home Cart 0 Sign in  
X

[ CAS No. 57764-49-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 57764-49-5
Chemical Structure| 57764-49-5
Chemical Structure| 57764-49-5
Structure of 57764-49-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 57764-49-5 ]

Related Doc. of [ 57764-49-5 ]

Alternatived Products of [ 57764-49-5 ]

Product Details of [ 57764-49-5 ]

CAS No. :57764-49-5 MDL No. :MFCD06659787
Formula : C10H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :IRTACBSCHHOIPA-UHFFFAOYSA-N
M.W : 191.18 Pubchem ID :14177940
Synonyms :

Calculated chemistry of [ 57764-49-5 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.2
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.1
TPSA : 52.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 2.26
Log Po/w (WLOGP) : 2.0
Log Po/w (MLOGP) : 1.34
Log Po/w (SILICOS-IT) : 2.04
Consensus Log Po/w : 2.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.73
Solubility : 0.359 mg/ml ; 0.00188 mol/l
Class : Soluble
Log S (Ali) : -3.0
Solubility : 0.193 mg/ml ; 0.00101 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.4
Solubility : 0.0765 mg/ml ; 0.0004 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.56

Safety of [ 57764-49-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 57764-49-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 57764-49-5 ]
  • Downstream synthetic route of [ 57764-49-5 ]

[ 57764-49-5 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 57764-49-5 ]
  • [ 28691-47-6 ]
Reference: [1] Patent: EP1346982, 2003, A1,
[2] Journal of the American Chemical Society, 1975, vol. 97, p. 7305 - 7312
[3] Journal of Medicinal Chemistry, 1994, vol. 37, # 15, p. 2308 - 2314
[4] Patent: WO2005/63767, 2005, A2, . Location in patent: Page/Page column 44-45
[5] Patent: WO2005/111038, 2005, A2, . Location in patent: Page/Page column 66-67
[6] Patent: US2005/250808, 2005, A1, . Location in patent: Page/Page column 40
[7] Patent: US4853027, 1989, A,
  • 2
  • [ 651780-27-7 ]
  • [ 57764-49-5 ]
YieldReaction ConditionsOperation in experiment
96% With hydrogen; triethylamine In ethanol at 0℃; for 1 h; 10percent Palladium on carbon (1.5g) and triethylamine (7.5 g, 82.4 mmol) were added to a solution of ethyl 6-bromobenzisoxazole-3-carboxylate (20g, 0. 081mol) in ethanol (300ml) at 0 °C under an atmosphere of nitrogen. The nitrogen atmosphere was removed by evacuation and replaced with hydrogen gas, and the reaction mixture was maintained for 1 hour. The hydrogen atmosphere was removed by evacuation and replaced with nitrogen gas, and the palladium removed by filtration through Celite. The filter cake was washed with ethanol (3 x 50 mL) and the filtrates were concentrated. The residue was dissolved in dichloromethane (200 mL) and the solution was washed with water (4 x 50 mL), dried (sodium sulfate) and evaporated to provide 13.0 g of the product as a yellow solid (96percent). The ester was saponified using sodium hydroxide to provide the acid. The acid was coupled with the bicyclobase according to procedure A. Literature reference: Angell, R. M.; Baldwin, I. R.; Bamborough, P.; Deboeck, N. M.; Longstaff, T.; Swanson, S. W004010995A1 The following acid was prepared using this method: 1,2-Benzisoxazole-3-carboxylic acid.
96% With hydrogen; triethylamine In ethanol at 0℃; for 1 h; Diethyl malonate (12.6 g, 79 mmol) was added to a suspension of sodium hydride (3.16 g, 132 mmol) in dimethylsulfoxide (60 ml) over 30 min. The temperature of the reaction rose to 60 °C and the mixture clarified. 1,4-Dibromo-2-nitrobenzene (10 g, 36.0 mmol) was added and the solution was maintained for 2 h at 100 °C. The reaction mixture was allowed to cool to rt and was poured into ice (300g-400g). The precipitated solids were isolated by filtration and dried to provide 11.0 g of the product (89percent). The ester (11.0 g, 32.0 mmol) was diluted with a 2 N solution of sodium hydroxide (32 mL, 63 mmol) and the reaction mixture was maintained at room temperature for 16 h. The aqueous layer was extracted with dichloromethane (20 mL) and was acidified. The precipitated solids were isolated by filtration and dried to provide 7.00 g of the acid (89percent). Sulfuric acid (1 mL) was added to a solution of the acid (7.00 g, 27.0 mmol) in ethanol (60 ml). The reaction mixture was warmed to reflux, maintained for 2 h, and was concentrated under reduce pressure. The residue was partitioned between ethyl acetate (250 mL) and saturated sodium carbonate (50 mL) and the organic layer was washed with saturated sodium carbonate (50 mL) and brine (50 mL). The organic layer was dried (sodium sulfate) and concentrated to provide 8.00 g (98percent) of the ester as a liquid. Under N2 atmosphere, sodium ethylate was formed with sodium (33.5 g, 1.46 mol) in ethanol (1.0 L). Isoamylnitrite (225 mL) was added to a solution of the ester (420 g, 1.46 mol) in ethanol (3 L) in a 10 L three-necked round bottom flask and the mixture was warmed to 60 °C. A solution of sodium ethoxide, prepared from sodium metal (33.5 g, 1.46 mmol) in ethanol (1 L) was added dropwise and the reaction mixture was maintained for 2 h. The reaction mixture was allowed to cool to rt and was neutralized with 2 N hydrochloric acid. The reaction mixture was extracted with ethyl acetate (4 x 2L) and the combined organic layers were washed with water (2 x 1 L) and brine (2 x 1 L) and dried (sodium sulfate). The residue was purified by chromatography (1/1 to 0/1 hexane/ethyl acetate) to provide 110 g of the product ( 28percent). 10percent Palladium on carbon (1.5g) and triethylamine (7.5 g, 82.4 mmol) were added to a solution of ethyl 6-bromobenzisoxazole-3-carboxylate (20g, 0.081mol) in ethanol (300ml) at 0 °C under an atmosphere of nitrogen. The nitrogen atmosphere was removed by evacuation and replaced with hydrogen gas, and the reaction mixture was maintained for 1 hour. The hydrogen atmosphere was removed by evacuation and replaced with nitrogen gas, and the palladium removed'by filtration through Celite. The filter cake was washed with ethanol (3 x 50 mL) and the filtrates were concentrated. The residue was- dissolved in dichloromethane (200 mL) and the solution was washed with water (4 x 50 mL), dried (sodium sulfate) and evaporated to provide 13.0 g of the product as a yellow solid (96percent). The ester was saponified using sodium hydroxide to provide the acid. The acid was coupled with 1,4-diazabicyclo[3.2.2]nonane according to procedure A.
96% With hydrogen; triethylamine In ethanol at 0℃; for 1 h; 10percent Palladium on carbon (1.5 g) and triethylamine (7.5 g, 82.4 mmol) were added to a solution of ethyl 6-bromobenzisoxazole-3-carboxylate (20 g, 0.081 mol) in ethanol (300ml) at 0° C. under an atmosphere of nitrogen. The nitrogen atmosphere was removed by evacuation and replaced with hydrogen gas, and the reaction mixture was maintained for 1 hour. The hydrogen atmosphere was removed by evacuation and replaced with nitrogen gas, and the palladium removed by filtration through Celite. The filter cake was washed with ethanol (3.x.50 mL) and the filtrates were concentrated. The residue was dissolved in dichloromethane (200 mL) and the solution was washed with water (4.x.50 mL), dried (sodium sulfate) and evaporated to provide 13.0 g of the product as a yellow solid (96percent). The ester was saponified using sodium hydroxide to provide the acid. The acid was coupled with the bicyclobase according to procedure A.
Reference: [1] Patent: WO2005/63767, 2005, A2, . Location in patent: Page/Page column 44-45
[2] Patent: WO2005/111038, 2005, A2, . Location in patent: Page/Page column 66-67
[3] Patent: US2005/250808, 2005, A1, . Location in patent: Page/Page column 40
  • 3
  • [ 57764-48-4 ]
  • [ 57764-49-5 ]
YieldReaction ConditionsOperation in experiment
41% With sodium hydride In N,N-dimethyl-formamide at 130℃; for 8.41667 h; A solution of the nitro oxime a (5.0 g, 21.0 mmol) prepared according to the procedures described by Kemp et al. (/. Am. Chem. Soc. 1975, 97, 7305-7312) in DMF (30 mL) was added drop wise over 25 min to a vigorously stirred suspension of hexane-washed NaH (60percent in mineral oil, 840 mg, 21.0 mmol) in DMF (40 mL) under N2. The resulting dark colored solution was heated slowly to 130 0C for 8 h. It was diluted with water (200 mL), extracted with EtOAc (2 x 200 mL), washed the EtOAc with brine, dried (MgSO4), and concentrated in vacuo. The crude product was adsorbed on to Celite and purified by ISCO CombiFlash 120 g EPO <DP n="90"/>column (1-10percent ethyl acetate-hexane) to afford 1.6 g (41percent) of benzisoxazole b as an off white solid.
Reference: [1] Patent: WO2006/69063, 2006, A1, . Location in patent: Page/Page column 88-89
[2] Journal of the American Chemical Society, 1975, vol. 97, p. 7305 - 7312
[3] Journal of Medicinal Chemistry, 1994, vol. 37, # 15, p. 2308 - 2314
  • 4
  • [ 57764-48-4 ]
  • [ 57764-49-5 ]
Reference: [1] Patent: US4853027, 1989, A,
  • 5
  • [ 3740-52-1 ]
  • [ 57764-49-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1994, vol. 37, # 15, p. 2308 - 2314
  • 6
  • [ 31912-02-4 ]
  • [ 57764-49-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1994, vol. 37, # 15, p. 2308 - 2314
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 57764-49-5 ]

Esters

Chemical Structure| 57764-50-8

[ 57764-50-8 ]

Ethyl 6-hydroxybenzo[d]isoxazole-3-carboxylate

Similarity: 0.99

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.84

Chemical Structure| 51677-09-9

[ 51677-09-9 ]

Methyl 5-phenylisoxazole-3-carboxylate

Similarity: 0.81

Chemical Structure| 651780-27-7

[ 651780-27-7 ]

Ethyl 6-bromobenzo[d]isoxazole-3-carboxylate

Similarity: 0.81

Chemical Structure| 1123169-23-2

[ 1123169-23-2 ]

Methyl 6-bromobenzo[d]isoxazole-3-carboxylate

Similarity: 0.79

Related Parent Nucleus of
[ 57764-49-5 ]

Benzisoxazoles

Chemical Structure| 57764-50-8

[ 57764-50-8 ]

Ethyl 6-hydroxybenzo[d]isoxazole-3-carboxylate

Similarity: 0.99

Chemical Structure| 28691-47-6

[ 28691-47-6 ]

Benzo[d]isoxazole-3-carboxylic acid

Similarity: 0.91

Chemical Structure| 651780-27-7

[ 651780-27-7 ]

Ethyl 6-bromobenzo[d]isoxazole-3-carboxylate

Similarity: 0.81

Chemical Structure| 1123169-23-2

[ 1123169-23-2 ]

Methyl 6-bromobenzo[d]isoxazole-3-carboxylate

Similarity: 0.79

Chemical Structure| 28691-49-8

[ 28691-49-8 ]

6-Chlorobenzo[d]isoxazole-3-carboxylic acid

Similarity: 0.79